Integral Molecular Presents Data on Monoclonal Antibodies (MAbs) Against SLC2A4 (GLUT4), a Critical Target...
Integral Molecular Presents Data on Monoclonal Antibodies (MAbs) Against SLC2A4 (GLUT4), a Critical Target for Diabetes
Treatment targets for men with advanced prostate cancers
Treatment targets for men with advanced prostate cancers
Treatment targets for men with advanced prostate cancers
Treatment targets for men with advanced prostate cancers
Medicago Awarded “Best New Vaccine Technology/Platform” at the World Vaccine Congress
Medicago Awarded "Best New Vaccine Technology/Platform" at the World Vaccine Congress
Cutting-Edge Discovery Points to Potential Treatment for Necrotizing Enterocolitis in Preemies
Cutting-Edge Discovery Points to Potential Treatment for Necrotizing Enterocolitis in Preemies
